In This Article:
As global markets navigate the complexities of rising inflation and shifting trade policies, U.S. stock indexes are nearing record highs, driven by investor optimism and strategic economic decisions. In this environment, dividend stocks like Thai Oil can offer stability and income potential, making them an attractive addition to a diversified portfolio amidst market volatility.
Top 10 Dividend Stocks
Name | Dividend Yield | Dividend Rating |
Guaranty Trust Holding (NGSE:GTCO) | 5.93% | ★★★★★★ |
Wuliangye YibinLtd (SZSE:000858) | 3.93% | ★★★★★★ |
Padma Oil (DSE:PADMAOIL) | 7.69% | ★★★★★★ |
Peoples Bancorp (NasdaqGS:PEBO) | 4.92% | ★★★★★★ |
Tsubakimoto Chain (TSE:6371) | 4.23% | ★★★★★★ |
CAC Holdings (TSE:4725) | 4.06% | ★★★★★★ |
Nihon Parkerizing (TSE:4095) | 3.92% | ★★★★★★ |
Southside Bancshares (NYSE:SBSI) | 4.68% | ★★★★★★ |
Guangxi LiuYao Group (SHSE:603368) | 3.40% | ★★★★★★ |
Citizens & Northern (NasdaqCM:CZNC) | 5.27% | ★★★★★★ |
Click here to see the full list of 1990 stocks from our Top Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Thai Oil
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Thai Oil Public Company Limited operates in oil refining, distribution, petrochemicals, and lube base oil sectors both in Thailand and internationally, with a market cap of THB58.64 billion.
Operations: Thai Oil's revenue segments primarily consist of Oil Refinery (THB497.53 billion), Aromatics and Lab (THB80.53 billion), Lube Base Oil Refinery (THB25.74 billion), Solvent (THB19.73 billion), and Power Generation (THB11.83 billion).
Dividend Yield: 7.5%
Thai Oil's dividend payments have been volatile over the past decade, with recent decreases highlighting this trend. Despite a low cash payout ratio of 14.1% and a reasonable payout ratio of 42.6%, ensuring dividends are covered by earnings and cash flows, the company's unstable dividend track record poses concerns for investors seeking reliability. The latest financial results show decreased net income to THB 9.96 billion, affecting overall profitability and potentially impacting future dividend stability.
Ono Pharmaceutical
Simply Wall St Dividend Rating: ★★★★★★
Overview: Ono Pharmaceutical Co., Ltd., along with its subsidiaries, is engaged in the production, purchase, and sale of pharmaceuticals and diagnostic reagents globally, with a market cap of ¥716.07 billion.
Operations: Ono Pharmaceutical Co., Ltd. generates revenue primarily from its Pharmaceutical Business, which amounts to ¥487.33 billion.